Kiniksa Pharmaceuticals Quick Start Program: Arcalyst

Funded

About

The Kiniksa Pharmaceuticals Quick Start Program: Arcalyst is designed to assist patients experiencing insurance-related delays in accessing their Arcalyst medication. This program offers eligible patients the opportunity to begin their Arcalyst treatment at no cost for up to 60 days while awaiting insurance authorization. By utilizing the Kiniksa Pharmaceuticals Quick Start Program: Arcalyst, patients can have uninterrupted access to their medication, ensuring they receive timely and effective treatment.

Insurance requirements: Commercially insured, Medicare / Medicaid

Enrollment Forms

Enrollment Form

Program Requirements

•Valid only for residents in the US and Puerto Rico

•Enrollment Required: Yes

•Coverage Required: No

•Needs Based: Yes

•Activation Required: No

Program Details

•The Quick Start program supports eligible patients with delay in coverage for treatment initiation while awaiting prior authorization at no cost

•Program offered for up to 60 days

•HCP and patient should complete the enrollment form

•Fax the enrollment form to 7816097826

•The Kiniksa One Connect team will evaluate and determine if the patient is eligible for the Quick Start Program; if the patient is eligible, they will notify and ship the medicine directly to the patient

•Contact the Kiniksa One Connect team at 1833KINIKSA (18335464572) for additional information

Enrollment Forms

Enrollment Form